Cargando…

Inhibition of Tumor Cell Invasion by Ubenimex (Bestatin) in vitro

We have investigated the effect of the immunomodulator ubenimex (bestatin) on tumor cell invasion of reconstituted basement membrane (Matrigel). The invasion of B16‐BL6 melanoma cells and Lewis lung carcinoma (3LL) cells into Matrigel‐coated filters was inhibited by the presence of bestatin in a con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saiki, Ikuo, Murata, Jun, Watanabe, Kunihito, Fujii, Hideji, Abe, Fuminori, Azuma, Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917861/ https://www.ncbi.nlm.nih.gov/pubmed/2513304 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01729.x

Ejemplares similares

Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13
por: Fujii, Hideji, et al.
Publicado: (1995)

Inhibition of Tumor Cell Arrest in Lungs by Antimetastatic Chitin Heparinoid
por: Murata, Jun, et al.
Publicado: (1990)

Differences in Chemotaxis to Fibronectin in Weakly and Highly Metastatic Tumor Cells
por: Murata, Jun, et al.
Publicado: (1992)

Inhibition of LTA4H by bestatin in human and mouse colorectal cancer
por: Zhao, Simin, et al.
Publicado: (2019)

Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection
por: Pulido-Cejudo, Gabriel, et al.
Publicado: (1997)

Effects of Sex Steroids and Growth Factors on Migration and Invasion of Endoraetrial Adenocarcinoma SNG‐M Cells in vitro
por: Ueda, Masatsugu, et al.
Publicado: (1996)

The Analgesic Activity of Bestatin as a Potent APN Inhibitor
por: Jia, Mei-Rong, et al.
Publicado: (2010)

A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma
por: YAMASHITA, MASAFUMI, et al.
Publicado: (2016)

Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions
por: Grujić, Mirjana, et al.
Publicado: (2002)

Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro
por: Bourinbaiar, A.S., et al.
Publicado: (1994)

Inhibitory Effect of Recombinant Fibronectin Polypeptides on the Adhesion of Liver‐metastatic Lymphoma Cells to Hepatic Sinusoidal Endothelial Cells and Tumor Invasion
por: Yoneda, Junya, et al.
Publicado: (1994)

Clinical efficacy of intravesical gemcitabine combined with ubenimex in patients with non-muscle-invasive bladder carcinoma after transurethral resection of bladder tumor
por: Shao, Li-jun, et al.
Publicado: (2022)

Inhibition of aminopeptidases N, A and W: A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme
por: Tieku, Stephen, et al.
Publicado: (1992)

Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC
por: Cao, Jiangying, et al.
Publicado: (2020)

Inhibitory Effect of Chitin Heparinoids on the Lung Metastasis of B16‐BL6 Melanoma
por: Murata, Jun, et al.
Publicado: (1989)

KBE009: A Bestatin-Like Inhibitor of the Trypanosoma cruzi Acidic M17 Aminopeptidase with In Vitro Anti-Trypanosomal Activity
por: González-Bacerio, Jorge, et al.
Publicado: (2021)

Inhibitory Effect of Antimetastatic Fusion Polypeptide of Human Fibronectin on Tumor Cell Adhesion to Extracellular Matrices
por: Matsutnoto, Yoshihiro, et al.
Publicado: (1991)

Inhibition of Tumor‐induced Angiogenesis by a Synthetic Lipid A Analogue with Low Endotoxicity, DT‐5461
por: Sato, Katsuaki, et al.
Publicado: (1995)

DT‐5461, a New Synthetic Lipid A Analogue, Inhibits Lung and Liver Metastasis of Tumor in Mice
por: Sato, Katsuaki, et al.
Publicado: (1992)

Recombinant Fusion Polypeptide with Cell‐ and Heparin‐binding Domains of Fibronectin Inhibits Liver Metastasis of L5178Y‐ML25 Lymphoma Cells
por: Saiki, Ikuo, et al.
Publicado: (1991)

Inhibition of Lung Metastasis by Synthetic and Recombinant Fragments of Human Fibronectin with Functional Domains
por: Saiki, Ikuo, et al.
Publicado: (1990)

Ubenimex Suppresses the Ability of Migration and Invasion in Gastric Cancer Cells by Alleviating the Activity of the CD13/NAB1/MAPK Pathway
por: Liu, Xuehui, et al.
Publicado: (2021)

Autophagy flux inhibition, G2/M cell cycle arrest and apoptosis induction by ubenimex in glioma cell lines
por: Han, Liping, et al.
Publicado: (2017)

Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism
por: Liu, Shuai, et al.
Publicado: (2016)

Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells
por: Han, Liping, et al.
Publicado: (2017)

Inhibitory Effect of Fibronectin and Its Recombinant Polypeptides on the Adhesion of Metastatic Melanoma Cells to Laminin
por: Saiki, Ikuo, et al.
Publicado: (1991)

Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines
por: Kim, Hyeong Won, et al.
Publicado: (2023)

Ubenimex Activates the E‐Cadherin‐mediated Adhesion of a Breast Cancer Cell Line YMB‐S
por: Fujioka, Seiji, et al.
Publicado: (1995)

Ubenimex, an APN inhibitor, could serve as an anti-tumor drug in RT112 and 5637 cells by operating in an Akt-associated manner
por: Wang, Xiaoqing, et al.
Publicado: (2018)

Ubenimex Combined with Pemetrexed Upregulates SOCS1 to Inhibit Lung Adenocarcinoma Progression via the JAK2-STAT3 Signaling Pathway
por: Chen, Quan, et al.
Publicado: (2022)

Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
por: Tsukamoto, Hirohisa, et al.
Publicado: (2008)

Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells
por: Guo, Qie, et al.
Publicado: (2017)

Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer
por: Shi, Yunyan, et al.
Publicado: (2023)

Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer
por: Zhang, Jian, et al.
Publicado: (2023)

Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P‐glycoprotein expression level in non‐small lung cancer
por: Wan, Jun, et al.
Publicado: (2020)

Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins
por: Guo, Qie, et al.
Publicado: (2019)

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells
por: Wang, Xiaoqing, et al.
Publicado: (2018)

Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway
por: Wang, Yanjun, et al.
Publicado: (2019)

CD13 downregulation mediated by ubenimex inhibits autophagy to overcome 5-FU resistance by disturbing the EMP3/FAK/NF-κB pathway in gastric cancer cells
por: Xiu, Ting, et al.
Publicado: (2022)

Antimetastatic Activity of Polymeric RGDT Peptides Conjugated with Poly(ethylene glycol)
por: Saiki, Ikuo, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_cq47mvibn32tq28jv1voie51m0